A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx

NCT04083222 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Placebo
DRUG: ISIS 757456

Sponsor

Ionis Pharmaceuticals, Inc.